CRC Tier 2 - Chronic oral disease (COD) aetiology

John Maher

Phase 1 trial: T4 immunotherapy of head and neck cancer

Other pharynx Oesophagus Nasopharynx Lip, oral cavity Larynx

Anil Chaturvedi

Oral Cancer Screening Efficacy Analyses

Trachea, bronchus and lung Other pharynx Lip, oral cavity Larynx

Brian J Reid

Barretts Esophagus: Predictors of Progression

Oesophagus

Pathology

Maxwell Kligerman

Epidemiology of Oral HPV induced Head and Neck Cancer in Haiti

Other pharynx Lip, oral cavity Larynx

Vern L. Schramm

Methylthioadenosine Phosphorylase and AdoMet Synthetase in Cancer

Prostate Other pharynx Oesophagus Nasopharynx Lip, oral cavity Larynx Colorectum Breast

Jean William Pape

Global Health Research and Training in HIV and Tuberculosis

Trachea, bronchus and lung Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Kaposi sarcoma Hodgkin lymphoma Colorectum Cervix uteri

Sally Roberts

The role of oncogenic HPV E6-PDZ interactions in the viral life cycle and in HPV-induced malignancy

Other pharynx Oesophagus Nasopharynx Lip, oral cavity Larynx Cervix uteri

Michael Cook

microRNA and esophageal adenocarcinoma

Oesophagus

Pathology

Georg E. Luebeck

Esophageal Cancer from Cells to Population: A Multiscale Approach

Oesophagus